Table 4 Association between procollagen 11A1 expression and clinicopathological features
Anti-procollagen 11A1 immunostaining (Median =2) | ||||
|---|---|---|---|---|
Low (≤2) | High (>2) | p | ||
Age (Median 70 years) | ≤ 70 years | 13 | 14 | 0.304 |
> 70 years | 15 | 9 | ||
Gender | Female | 18 | 14 | 0.802 |
Male | 10 | 9 | ||
Localization | Ascending colon | 9 | 12 | 0.260 |
Descending colon | 6 | 2 | ||
Sigmoid | 13 | 9 | 0.200 | |
Tumor size (Median = 3.7 cm) | Small ≤3.7 cm | 12 | 14 | |
Large >3.7 cm | 16 | 9 | 0.370 | |
Differentiation | Well differentiated | 12 | 7 | |
Moderately differentiated | 15 | 13 | ||
Poorly differentiated | 1 | 3 | ||
T | T1-T2 | 8 | 2 | 0.075 |
T3-T4 | 20 | 21 | ||
N | Absent | 17 | 8 | |
Present | 11 | 15 | 0.059 | |
M | Absent | 25 | 14 | |
Present | 3 | 9 | 0.017 | |
Stage grouping | I | 7 | 1 | 0.141 |
IIA | 7 | 5 | ||
IIB | 2 | 2 | ||
IIIA | 1 | 0 | ||
IIIB | 6 | 3 | ||
IIIC | 2 | 3 | ||
IV | 3 | 9 | ||
Dukes staging | A | 7 | 1 | |
B | 9 | 7 | ||
C | 9 | 6 | 0.047 | |
D | 3 | 9 | ||